reported side effects of tipranavir
hypercholesterolemia
hypertriglyceridemia
comprehensive list of adverse effects
needed effects
tipranavir
unwanted side effects
medical attention
following side effects
taking tipranavir
check
doctor
tipranavir side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
frequent side effects
clinical trials with this drug
ritonavir
diarrhea/loose stools
nausea
fatigue
headache
vomiting
pyrexia
abdominal pain
hyperlipidemia
therapy
side effects
patients
using tipranavir/ritonavir
patients
comparator
manufacturer product information for ritonavir
elevated triglycerides
elevated cholesterol
hypertriglyceridemia
hyperlipidemia
dehydration
appetiteuncommon
anorexia
diabetes mellitus
hyperamylasemia
hypercholesterolemia
hyperglycemiafrequency
mitochondrial toxicity
porphyria cutanea tardaantiretroviral therapy
frequency
redistribution/accumulation of body fat
including
central obesity
dorsocervical fat enlargement
peripheral wasting
facial wasting
breast enlargement
cushingoid appearance
increased blood lipid levels
glucose levelsprotease inhibitor therapy
postmarketing reports
new onset diabetes mellitus
exacerbation
preexisting diabetes mellitus
hyperglycemia
diabetic ketoacidosis
elevated triglycerides
grade
mg/dl
grade
mg/dl
grade
mg/dl
cholesterol
grade
mg/dl
grade
mg/dl
grade
mg/dl
weeks in controlled trials
grade
alt
ast elevations
times
upper limit of normal
uln
alt elevations
grade
uln
grade
uln
grade
uln
ast elevations
grade
grade
grade
weeks in controlled trials
controlled clinical trials
weeks
patients
grade
alt
ast elevations
grade
hepatic transaminase elevations
therapy-experienced patients in large studies
therapy-naive patients in study
studies
weeks
elevated alt
ast at baseline
hepatitis b
c coinfection
risk factors for such elevations in the large studies
patients
therapy with this drug
ritonavir
clinical hepatitis
hepatic decompensation
including
fatalities
drug
ritonavir
patients with advanced hiv
disease
taking multiple concomitant medications
significant liver toxicity
drug
ritonavir
least clinical trials
frequency of transaminase elevations
drug
ritonavir
comparator
elevated alt
ast
hepatic transaminases
elevated alt
elevated ast
elevated ggtuncommon
increased hepatic enzymes
cytolytic hepatitis
abnormal liver function tests
hepatitis
toxic hepatitis
hepatic steatosisrare
hepatic failure
including fatalities
hyperbilirubinemiafrequency
clinical hepatitis
hepatic decompensation
liver toxicity
hepatic impairment
diarrhea
nauseacommon
vomiting
elevated amylase
abdominal pain
upper abdominal pain
abdominal distension
dyspepsia
flatulence
elevated lipaseuncommon
gastroesophageal reflux disease
pancreatitis
elevated amylase
grade
uln
grade
uln
weeks in controlled trials
rash
including with joint pain/stiffness
throat tightness
generalized pruritus
myalgia
fever
erythema
desquamation
mucosal erosions
pruritusuncommon
exanthem
lipoatrophy
lipohypertrophy
lipodystrophyrare
facial wastingfrequency
urticarial rash
maculopapular rash
photosensitivity
rash
joint pain/stiffness
throat tightness
generalized pruritus
rash
including
urticarial rash
maculopapular rash
possible photosensitivity
males
females
drug
ritonavir
weeks of therapy
time
onset
duration of rash
days
cases of rash
conjunction with joint pain
stiffness
throat tightness
generalized pruritus
cases of rash
myalgia
fever
erythema
desquamation
mucosal erosions
rash
pediatric patients
adults
decreased wbc counts
anemia
neutropeniauncommon
thrombocytopeniafrequency
bleeding event
protease inhibitor therapy
frequency
increased bleeding
including
spontaneous skin hematomas
hemarthrosis
hemophiliacs
decreased wbc count
grade
mcl
grade
mcl
weeks in controlled trials
increased bleeding
including
spontaneous skin hematomas
hemarthrosis
patients with hemophilia type a
b
protease inhibitors
reported cases
treatment with protease inhibitors
patients
additional factor
causal relationship between protease inhibitor therapy
episodes
myalgiauncommon
muscle spasmsfrequency
muscle cramps
elevated creatine phosphokinase
cpk
combination
antiretroviral therapy
frequency
osteonecrosisprotease inhibitor therapy
rhabdomyolysis-frequency
increased cpk
myalgia
myositis
cases of fatal
nonfatal intracranial hemorrhage
drug
ritonavir
patients
other medical conditions
using
using concomitant medications
events
pattern of abnormal hematologic
coagulation parameters
patients in general
preceding development of intracranial hemorrhage
increased risk of intracranial hemorrhage
patients with advanced hiv disease/aids
clinical trials with this drug
headache
peripheral neuropathyuncommon
dizziness
somnolence
intracranial hemorrhagefrequency
cerebrovascular accident
pyrexia
fatigue
weightuncommon
influenza-like illness
malaisefrequency
asthenia
reactivation of herpes simplex
reactivation of varicella zoster
sepsisantiretroviral therapy
frequency
increased weight
insomniauncommon
sleep disorderfrequency
depression
dyspneafrequency
bronchitis
cough
nasopharyngitis
upper respiratory tract infection
pneumonia
epistaxis
hypersensitivity reactions
renal failurefrequency
renal insufficiency
frequency
immune reconstitution/reactivation syndrome
autoimmune disorders in the setting of immune reconstitution
graves
disease
polymyositis
guillain-barre syndrome
side effects of tipranavir
fda
healthcare professional for medical advice
bleeding gums
confusion
cough producing mucus
coughing up blood
difficulty with breathing
swallowing
dizziness
fever
general feeling of tiredness
weakness
headache
increased menstrual flow
vaginal bleeding
loss of appetite
nausea or vomiting
nosebleeds
paralysis
prolonged bleeding from cuts
tarry
light-colored stools
dark brown urine
sudden severe weakness
tightness in the chest
unusual bleeding
stomach pain
yellow eyes
skin
diarrhea
stomach pain
cough
discouragement
fat redistribution
feeling
irritability
lack of appetite
lack
loss of strength
loss of interest
pleasure
rash
trouble concentrating
trouble sleeping